Clinical Trials
LabCorp Transforms the Clinical Trial Experience And Streamlines the Druag Development Process
LabCorp , a leading global life sciences company that is focused on advancing health and guiding patient care decisions, announced new capabilities that will transform the clinical trial experience with the goal of streamlining the drug development process. This...
Press Releases
Thermo Fisher Scientific Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell
Thermo Fisher Scientific Inc., the world leader in serving science, announced it has received an expansion of its Emergency Use Authorization (EUA) for the TaqPath COVID-19 Combo Kit to include an additional sample collection method provided by Everlywell, a...
Press Releases
Catalent Launches OptiGel DR, a Delayed/Enteric Release Softgel for Pharmaceutical and Nutraceutical Applications
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced the launch of OptiGel® DR technology for the formulation and manufacture of delayed/enteric release...
Press Releases
Fujifilm Partners with Carelink Pharmaceutical in Deploying Anti-influenza Drug Avigan Tablets in China
FUJIFILM Toyama Chemical Co., Ltd. has announced that the company has partnered with Chinese pharmaceutical company Carelink Pharmaceutical Co., Ltd. (hereinafter “Carelink”) in deploying anti-influenza drug Avigan® Tablets in China. Going forward, through a future application and approval of...
Drug Research
RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate
RedHill Biopharma, a specialty biopharmaceutical company, has announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib, currently in swiftly progressing global Phase II/III and US Phase II studies for severe COVID-19 pneumonia,...
Drug Research
BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery and Disease Research
BioIVT, a leading provider of research models and services for drug and diagnostic development, launched its HEPATOMUNE® kit, a long-term, stable, in vitro model for evaluating immune-related and inflammation-mediated liver injury.
HEPATOMUNE cultures are composed of hepatocytes, stromal cells and...
Drug Research
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment
Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full scope of its development services from cell line development, process development, to non-clinical and clinical material manufacturing. Under...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read